Bio Protocol vs SuperVerse — how do they compare? Bio Protocol trades at Rp513.25 (market cap Rp1,15T, Rp256,3M 24h volume), while SuperVerse trades at Rp1,541 (market cap Rp983,18M, Rp56,13M 24h volume). The key difference: Bio Protocol is far larger — about 1169.7× SuperVerse's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 640,2M / 1.000M SUPER (65%) for SuperVerse. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and SuperVerse for 27 Days on average.
| BIO | SUPER | |
|---|---|---|
Market Cap | Rp1,15T | Rp983,18M |
Volume (24h) | Rp256,3M | Rp56,13M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 640,2M / 1.000M SUPER (65%) |
Typical Hold Time | 16 Days | 27 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →SuperVerse is a cross-chain decentralized finance (DeFi) protocol built to facilitate the launching of new non-fungible tokens (NFTs) without the need for programming. A marketplace and an innovative set of tools allow any project to deploy a farm with its own rules. The SUPER token gives users access to a range of opportunities in the crypto space through SUPERVERSE, Partner Video Games and frequent NFT drops.
Read more on SUPER →